Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Multi-center, Randomized, Double-blind, Parallel-group Vehicle and Active Controlled Study to Compare the Efficacy and Safety of CD0271 0.3% / CD1579 2.5% Topical Gel Versus Topical Gel Vehicle in Subjects With Acne Vulgaris
Brief Summary: The study hypothesis are based on the assumption that :

* CD0271 0.3%/CD1579 2.5% Gel provides superior clinical efficacy compared with Topical Gel Vehicle in the overall population and in the subgroup of severe Subjects
* CD0271 0.3%/CD1579 2.5% Gel applied once daily for up to 12 weeks has an acceptable safety and tolerability profile


Options:
A: Arm Label: Duac® fixed dose combination gel; Type: EXPERIMENTAL; Interventions: Drug: Duac® fixed dose combination gel | Arm Label: Combination therapy: ADA 0.1% gel + CLDM 1% gel; Type: ACTIVE_COMPARATOR; Interventions: Drug: ADA 0.1% gel, Drug: CLDM 1% gel | Intervention Type: DRUG; Name: Duac® fixed dose combination gel; Assigned to Arm(s): Duac® fixed dose combination gel | Intervention Type: DRUG; Name: ADA 0.1% gel; Assigned to Arm(s): Combination therapy: ADA 0.1% gel + CLDM 1% gel | Intervention Type: DRUG; Name: CLDM 1% gel; Assigned to Arm(s): Combination therapy: ADA 0.1% gel + CLDM 1% gel
B: Arm Label: Part 1: ABPO Forte Gel; Type: EXPERIMENTAL; Interventions: Drug: ABPO Forte Gel | Arm Label: Part 1: ABPO Forte Vehicle Gel; Type: PLACEBO_COMPARATOR; Interventions: Drug: Vehicle gel | Arm Label: Part 2: ABPO Forte Gel; Type: EXPERIMENTAL; Interventions: Drug: ABPO Forte Gel | Arm Label: Part 2: ABPO Forte Vehicle Gel; Type: PLACEBO_COMPARATOR; Interventions: Drug: Vehicle gel | Intervention Type: DRUG; Name: ABPO Forte Gel; Assigned to Arm(s): Part 1: ABPO Forte Gel, Part 2: ABPO Forte Gel | Intervention Type: DRUG; Name: Vehicle gel; Assigned to Arm(s): Part 1: ABPO Forte Vehicle Gel, Part 2: ABPO Forte Vehicle Gel
C: Arm Label: CD0271 0.3% /CD1579 2.5% Gel; Type: EXPERIMENTAL; Interventions: Drug: CD0271 0.3% / CD1579 2.5% | Arm Label: CD0271 0.1% / CD1579 2.5%; Type: ACTIVE_COMPARATOR; Interventions: Drug: CD0271 0.1% / CD1579 2.5% | Arm Label: Topical Gel Vehicle; Type: PLACEBO_COMPARATOR; Interventions: Drug: Topical Gel Vehicle | Intervention Type: DRUG; Name: CD0271 0.3% / CD1579 2.5%; Assigned to Arm(s): CD0271 0.3% /CD1579 2.5% Gel | Intervention Type: DRUG; Name: CD0271 0.1% / CD1579 2.5%; Assigned to Arm(s): CD0271 0.1% / CD1579 2.5% | Intervention Type: DRUG; Name: Topical Gel Vehicle; Assigned to Arm(s): Topical Gel Vehicle
D: Arm Label: Adapalene/Benzoyl Peroxide Gel; Type: EXPERIMENTAL; Interventions: Drug: Adapalene/Benzoyl Peroxide | Arm Label: Adapalene Gel, 0.1%; Type: EXPERIMENTAL; Interventions: Drug: Adapalene Gel, 0.1% | Arm Label: Benzoyl Peroxide Gel 2.5%; Type: EXPERIMENTAL; Interventions: Drug: Benzoyl Peroxide Gel 2.5% | Arm Label: Gel Vehicle; Type: PLACEBO_COMPARATOR; Interventions: Drug: Gel Vehicle | Intervention Type: DRUG; Name: Adapalene/Benzoyl Peroxide; Assigned to Arm(s): Adapalene/Benzoyl Peroxide Gel | Intervention Type: DRUG; Name: Adapalene Gel, 0.1%; Assigned to Arm(s): Adapalene Gel, 0.1% | Intervention Type: DRUG; Name: Benzoyl Peroxide Gel 2.5%; Assigned to Arm(s): Benzoyl Peroxide Gel 2.5% | Intervention Type: DRUG; Name: Gel Vehicle; Assigned to Arm(s): Gel Vehicle

Answer: C